Hemizygous <i>SACS</i> Variant in a Czech Patient With Autosomal Recessive Spastic Ataxia of Charlevoix–Saguenay

ABSTRACT Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS; MIM 270550) is a rare neurodegenerative disorder caused by pathogenic variants in the SACS gene. We report the case of a 27‐year‐old male patient from the Czech Republic with early‐onset progressive neurological symptoms consistent with ARSACS. Clinical manifestations included delayed motor development, cerebellar ataxia, spastic paraparesis of the lower limbs, and progressive gait impairment. Whole‐exome sequencing identified compound heterozygosity for two pathogenic variants in the SACS gene: a maternally inherited nonsense variant, c.1162C&gt;T, p.(Gln388*), present in a hemizygous state due to a de novo microdeletion encompassing the entire SACS gene on the paternally inherited chromosome. This case expands the molecular spectrum of ARSACS by reporting a novel nonsense variant in a hemizygous state, underscoring the diagnostic value of integrating sequence and copy number analysis derived from WES data in patients with hereditary spastic ataxia.

Authors

Institutions

Publication Details

Journal
Neurology and Clinical Neuroscience
Published
2026-06-26
DOI
https://doi.org/10.1002/ncn3.70138
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hemizygous SACS Variant in a Czech Patient With Autosomal Recessive Spastic Ataxia of Charlevoix–Saguenay

Anna Uhrová Mészárosová, Lucie Osičková, Dana Šafka Brožková, Martin Nezval et al.
Neurology and Clinical Neuroscience
Genetic Neurodegenerative Diseases
article

Hemizygous SACS Variant in a Czech Patient With Autosomal Recessive Spastic Ataxia of Charlevoix–Saguenay

Anna Uhrová Mészárosová, Lucie Osičková, Dana Šafka Brožková, Martin Nezval, Tereza Staneková, Petra Polčáková, Petr Kucera, Alena Musilova
article en

Abstract

ABSTRACT Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS; MIM 270550) is a rare neurodegenerative disorder caused by pathogenic variants in the SACS gene. We report the case of a 27‐year‐old male patient from the Czech Republic with early‐onset progressive neurological symptoms consistent with ARSACS. Clinical manifestations included delayed motor development, cerebellar ataxia, spastic paraparesis of the lower limbs, and progressive gait impairment. Whole‐exome sequencing identified compound heterozygosity for two pathogenic variants in the SACS gene: a maternally inherited nonsense variant, c.1162C&gt;T, p.(Gln388*), present in a hemizygous state due to a de novo microdeletion encompassing the entire SACS gene on the paternally inherited chromosome. This case expands the molecular spectrum of ARSACS by reporting a novel nonsense variant in a hemizygous state, underscoring the diagnostic value of integrating sequence and copy number analysis derived from WES data in patients with hereditary spastic ataxia.

Neurology and Clinical Neuroscience
Charles University (CZ), University Hospital in Motol (CZ), University Hospital Olomouc (CZ), Palacký University Olomouc (CZ)
Ministerstvo Zdravotnictví Ceské Republiky
Good health and well-being
Openalex Percentile: Top 10%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.